Biological
PG4
PG4 is a biological therapy with 3 clinical trials. Currently 1 active trials ongoing. Historical success rate of 100.0%.
Total Trials
3
Max Phase
—
Type
BIOLOGICAL
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 1 completed trials
Completion Rate
100%(1/1)
Active Trials
1(33%)
Results Posted
0%(0 trials)
Phase Distribution
Ph phase_2
2
67%
Ph phase_3
1
33%
Phase Distribution
0
Early Stage
2
Mid Stage
1
Late Stage
Phase Distribution3 total trials
Phase 2Efficacy & side effects
2(66.7%)
Phase 3Large-scale testing
1(33.3%)
Highest Phase Reached
Phase 3Trial Status & Enrollment
Completion Rate
100.0%
1 of 1 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
1
trials recruiting
Total Trials
3
all time
Status Distribution
Active(2)
Completed(1)
Detailed Status
Completed1
Not yet recruiting1
Active, not recruiting1
Development Timeline
Analytics
Development Status
Total Trials
3
Active
1
Success Rate
100.0%
Most Advanced
Phase 3
Trials by Phase
Phase 22 (66.7%)
Phase 31 (33.3%)
Trials by Status
completed133%
not_yet_recruiting133%
active_not_recruiting133%
Recent Activity
1 active trials
Showing 3 of 3
not_yet_recruitingphase_3
A Study to Learn About the Safety of an Expanded Pneumococcal Vaccine in Healthy Infants
NCT07573462
active_not_recruitingphase_2
A Study to Learn About How a New Pneumococcal Vaccine Works in Infants
NCT06524414
completedphase_2
A Study to Learn About How a New Pneumococcal Vaccine Works in Children
NCT06531538
Clinical Trials (3)
Showing 3 of 3 trials
NCT07573462Phase 3
A Study to Learn About the Safety of an Expanded Pneumococcal Vaccine in Healthy Infants
NCT06524414Phase 2
A Study to Learn About How a New Pneumococcal Vaccine Works in Infants
NCT06531538Phase 2
A Study to Learn About How a New Pneumococcal Vaccine Works in Children
All 3 trials loaded
Drug Details
- Intervention Type
- BIOLOGICAL
- Total Trials
- 3